Drug therapy: Selective estrogen-receptor modulators - Mechanisms of action and application to clinical practice

被引：701

作者：

Riggs, BL

Hartmann, LC

机构：

[1] Mayo Clin & Mayo Fdn, Dept Internal Med, Div Endocrinol & Metab, Rochester, MN 55905 USA

[2] Mayo Clin & Mayo Fdn, Dept Oncol, Rochester, MN 55905 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2003年 / 348卷 / 07期

关键词：

D O I：

10.1056/NEJMra022219

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：618 / 629

页数：12

共 105 条

[1] Tamoxifen: Five versus ten years - Is the end in sight? [J].

Abrams, JA .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (09) :662-664

[2]

*ATLAS TRIAL, 2003, NIH CLIN TRIAL

[3] Raloxifene and cardiovascular events in osteoporotic postmenopausal women - Four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial [J].

Barrett-Connor, E ;

Grady, D ;

Sashegyi, A ;

Anderson, PW ;

Cox, DA ;

Hoszowski, K ;

Rautaharju, P ;

Harper, KD .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (07) :847-857

[4] Hormones and heart disease in women: Heart and estrogen progestin replacement study in perspective [J].

Barrett-Connor, E ;

Stuenkel, C .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (06) :1848-1853

[5]

Baum M, 2002, LANCET, V359, P2131

[6] Raloxifene and estrogen reduces progression of advanced atherosclerosis - a study in ovariectomized, cholesterol-fed rabbits [J].

Bjarnason, NH ;

Haarbo, J ;

Byrjalsen, I ;

Alexandersen, P ;

Kauffman, RF ;

Christiansen, C .

ATHEROSCLEROSIS, 2001, 154 (01) :97-102

[7] Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women:: Results of the tamoxifen or arimidex randomized group efficacy and tolerability study [J].

Bonneterre, J ;

Thürlimann, B ;

Robertson, JFR ;

Krzakowski, M ;

Mauriac, L ;

Koralewski, P ;

Vergote, I ;

Webster, A ;

Steinberg, M ;

von Euler, M .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (22) :3748-3757

[8] Estrogen receptors α and β are differentially expressed in developing human bone [J].

Bord, S ;

Horner, A ;

Beavan, S ;

Compston, E .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (05) :2309-2314

[9] Molecular basis of agonism and antagonism in the oestrogen receptor [J].

Brzozowski, AM ;

Pike, ACW ;

Dauter, Z ;

Hubbard, RE ;

Bonn, T ;

Engstrom, O ;

Ohman, L ;

Greene, GL ;

Gustafsson, JA ;

Carlquist, M .

NATURE, 1997, 389 (6652) :753-758

[10]

Buzdar AU, 1998, CLIN CANCER RES, V4, P527

← 1 2 3 4 5 6 7 8 9 10 →